News
EPHMRA Conference 2025: Integrating real world evidence into human factors testing criteria and reporting
Victoria Barnosky, PhD, FAHRA, Suazio, explores how evidence meets regulation, with her paper entitled...
Integrating real world evidence into human factors testing criteria and reporting.
Join us at the 2023 Basel chapter meeting for the paper ‘Forecasting: Better assumptions, better calibrations, better data’
The speaker for this session will be Paula Coyle, Director, Blueprint Partnership
Come and join us at the 2023 Basel chapter meeting for the paper...
‘Deploying AI Tools in Social Media monitoring, is AI eradicating the need for the researcher?’
At the 2023 Basel Chapter Meeting…
Mike Pepp, Director, Blueprint Partnership, will present his paper – ‘The AI pandemic: Just how far has AI Spread within Pharma and how quickly do tech experts see it spreading?’.
Carolyn Chamberlain, Global Commercial Director and Ed Corbett, Head of Consulting – Branding Science will be presenting their paper...
‘How improving your AIQ leads to better insights and better strategic decisions’
EPHMRA AI Community - Launch
September 7 2023, 13:30-14:30 UK time
Artificial Intelligence (AI) – it’s a topic rapidly evolving in our industry. EPHMRA is forming a new AI community to come together, to discuss the AI topics EPHMRA should address and the way forward.
Put 21 September in your diary and join us in Basel!
There are only 60 tickets available for the meeting – make sure you register and reserve one.
Upcoming Webinar - Supply Chain Forecasting – An introduction to a less well-known art
Friday 14 July at 13.00 – 14.00hrs UK time
Speaker: Richard Murgatroyd, Systems & Innovation Expert, Global Supply Chain at F. Hoffmann-La Roche Ltd.
Members might be interested to read guidance from the ICO on AI.
The guidance is suitable for businesses in the public, private and third sectors and includes:
Artificial intelligence (AI) and data protection
A detailed overview of how to apply the principles of the UK GDPR to the use of information in AI systems.
Panel Discussion: Embracing AI before it Embraces us: Navigating our way toward the future, staying relevant while elevating our value as an industry.
Convenor: Elizabeth Kehler, Adelphi Research
Contributors: Alex Kirkman, Strategic Insights Director Specialty Care Therapy Area, GSK and Vijay Chand, Director, Global Reporting, AstraZeneca